Litcius/Paper detail

Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial

Bo Qiu, Qiwen Li, Junling Liu, Yan Huang, Qingsong Pang, Zhengfei Zhu, Xi Yang, Bin Wang, Li Chen, JianLan Fang, Maosheng Lin, Xiaobo Jiang, Suping Guo, JinYu Guo, Daquan Wang, FangJie Liu, Chu Chu, Xiaoyan Huang, Chuanmiao Xie, Hui Liu

2021International Journal of Radiation Oncology*Biology*Physics48 citationsDOI

Topics & Concepts

MedicineProphylactic cranial irradiationRegimenEtoposideClinical endpointInternal medicineChemotherapyConfidence intervalLung cancerRandomized controlled trialConventional PCIRadiation therapyMulticenter trialChemotherapy regimenProgression-free survivalSurgeryMulticenter studyMyocardial infarctionLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial | Litcius